RecruitingNot ApplicableNCT05834920

Effects of Neurofeedback and Transcranial Pulse Stimulation on Attention


Sponsor

The University of Hong Kong

Enrollment

180 participants

Start Date

Mar 17, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The present study aims to examine and compare the effectiveness of transcranial pulse stimulation and neurofeedback among adults who are weak in attention.


Eligibility

Min Age: 20 Years

Inclusion Criteria5

  • Aged 20 years and above
  • Right-handed
  • Normal/corrected hearing and vision
  • Having basic literacy skills
  • Having sustained attention scores below the threshold

Exclusion Criteria10

  • Having medical history related to brain
  • Having mild cognitive impairment
  • Showing symptoms of depression and anxiety
  • Having intellectual disability based on IQ scores
  • Having diagnoses of any psychiatric or cognitive disorders besides attention deficit hyperactivity disorder (ADHD) inattentive and combined types
  • Having long-term history of smoking cigarettes
  • Engaged in alcohol and/or substance abuse
  • Having history of hemophilia or other blood clotting disorders or thrombosis
  • Having corticosteroid treatment within the last six weeks before first intervention
  • Having contraindications for MRI scanning

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial pulse stimulation (TPS)

Participants will be treated with the TPS device NEUROLITH (Storz Medical AG). Treatments will be administered for up to 12 sessions within 4 weeks, each session consisting of 6000 TPS pulses of 0.2 mJ/mm².

DEVICENeurofeedback

Participants will engage in a neurofeedback game designed to increase the ratio of theta/beta frequency bands in electroencephalography measurement. This intervention will be delivered for up to 12 sessions within 4 weeks.


Locations(1)

HKU InnoCentre of Clinical Neuropsychology

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05834920


Related Trials